• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
ConferencesThe CEO Initiative

How Pfizer’s CEO ruthlessly cut bureaucracy to deliver a COVID vaccine in record time

By
Alyssa Newcomb
Alyssa Newcomb
Down Arrow Button Icon
By
Alyssa Newcomb
Alyssa Newcomb
Down Arrow Button Icon
November 16, 2021, 11:15 AM ET

Pfizer has undoubtedly changed the world with its COVID-19 vaccine, which has been injected into millions of arms globally in an effort to stop the spread of the virus and keep people healthy.

Last year, the pharmaceutical company’s teams worked at record speed to develop and test an mRNA vaccine, which uses the information in a person’s cells to make a protein that triggers an immune response.

“It was a time that the world was really scared. It was a time we were all living things we had never lived before, never thought we would live,” Pfizer chairman and CEO Dr. Albert Bourla told the audience at Fortune’s CEO Initiative on Monday in Washington, D.C.

Saving lives and ending lockdowns were huge motivators, of course. But Bourla credits certain strategic decisions made by the company with helping it move more quickly toward a vaccine.

The CEO says Pfizer focused on ending internal and external bureaucracy that would otherwise slow its scientists down. The drugmaker didn’t take money from the government, because Bourla said Pfizer scientists would then have to lose time in committee meetings meticulously detailing how they were spending public funding. 

Bourla also made sure to embed himself with teams so decisions could be made faster. 

In organizations, “because of the silos, it is very difficult to make decisions,” he said. Having the CEO or another executive in meetings helped speed up Pfizer’s process. 

Pfizer’s team also operated with a sense of purpose, which he said was framed by the question: “If not us, then who?”

“It was a time that the people needed to rise to the occasion, no matter what,” said Bourla. 

One year after the first vaccine trial results were released, Pfizer’s impact has been undeniable. In addition to the vaccine, Pfizer also has an antiviral pill.

“If we didn’t have a vibrant life sciences sector, we wouldn’t be here today,” said the CEO.

More health care and Big Pharma coverage from Fortune:

  • Biden’s vaccine mandate may be tied up in court—but employers shouldn’t wait to enforce it, say legal experts
  • State Farm publicly supports NFL’s Aaron Rodgers after his vaccine comments—while quietly removing most of his ads
  • How Big Bird became the unlikely target of GOP senators
  • Denmark ditched its COVID rules 2 months ago. Now cases are up—and restrictions are coming back
  • Air purifiers and CO2 monitors are the new pencil and paper in classrooms

Subscribe to Fortune Daily to get essential business stories delivered straight to your inbox each morning.

About the Author
By Alyssa Newcomb
See full bioRight Arrow Button Icon

Latest from our Conferences

InnovationBrainstorm AI
Backflips are easy, stairs are hard: Robots still struggle with simple human movements, experts say
By Nicholas GordonDecember 11, 2025
2 days ago
ConferencesBrainstorm AI
Exelon CEO: The ‘warning lights are on’ for U.S. electric grid resilience and utility prices amid AI demand surge
By Jordan BlumDecember 9, 2025
4 days ago
AIBrainstorm Design
AI’s reliance on patterns can lead to ‘somewhat mediocre’ results, warns CEO of design consultancy IDEO
By Andrew StaplesDecember 9, 2025
4 days ago
Logo of Fortune Brainstorm AI conference
ConferencesBrainstorm AI
Fortune Brainstorm AI 2025 Livestream
By Fortune EditorsDecember 8, 2025
5 days ago
Workplace CultureBrainstorm Design
How two leaders used design thinking and a focus on outcomes to transform two Fortune 500 giants
By Christina PantinDecember 4, 2025
9 days ago
Workplace CultureBrainstorm Design
Designer Kevin Bethune: Bringing ‘disparate disciplines around the table’ is how leaders can ‘problem solve the future’
By Fortune EditorsDecember 3, 2025
10 days ago

Most Popular

placeholder alt text
Economy
Tariffs are taxes and they were used to finance the federal government until the 1913 income tax. A top economist breaks it down
By Kent JonesDecember 12, 2025
1 day ago
placeholder alt text
Success
Apple cofounder Ronald Wayne sold his 10% stake for $800 in 1976—today it’d be worth up to $400 billion
By Preston ForeDecember 12, 2025
1 day ago
placeholder alt text
Success
40% of Stanford undergrads receive disability accommodations—but it’s become a college-wide phenomenon as Gen Z try to succeed in the current climate
By Preston ForeDecember 12, 2025
1 day ago
placeholder alt text
Economy
For the first time since Trump’s tariff rollout, import tax revenue has fallen, threatening his lofty plans to slash the $38 trillion national debt
By Sasha RogelbergDecember 12, 2025
21 hours ago
placeholder alt text
Economy
The Fed just ‘Trump-proofed’ itself with a unanimous move to preempt a potential leadership shake-up
By Jason MaDecember 12, 2025
20 hours ago
placeholder alt text
Success
At 18, doctors gave him three hours to live. He played video games from his hospital bed—and now, he’s built a $10 million-a-year video game studio
By Preston ForeDecember 10, 2025
3 days ago
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.